Tops & Flops Stocks
Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Guerbet S.A. | 1.210% | -0.886% | -4.006% | 51.467% | 74.015% | -0.297% | -31.809% |
Biotest AG VZ | 1.190% | 1.969% | -6.159% | -16.987% | -16.452% | -26.629% | 19.630% |
Alnylam Pharmace. | 1.190% | 3.845% | 18.618% | 45.185% | 46.497% | 49.884% | 250.122% |
Pulmatrix Inc. | 1.180% | -2.286% | -6.557% | -19.718% | 4.396% | -87.333% | -88.768% |
Innoviva Inc. | 1.180% | 4.268% | -0.581% | 43.697% | 19.580% | 39.024% | 76.325% |
Principia Biopharma Inc | 1.180% | - | - | - | - | - | - |
Amplifon SpA | 1.170% | 2.474% | 1.031% | -3.637% | -6.218% | -32.700% | 27.981% |
Amedisys Inc. | 1.170% | 0.000% | -2.809% | 1.765% | 2.367% | -42.333% | -23.708% |
Oncopeptides AB | 1.170% | - | - | - | - | - | - |
Biocartis Group NV | 1.170% | - | - | - | - | - | - |
Becton, Dickinson & Co. | 1.160% | 2.690% | -1.001% | -15.985% | -1.538% | 3.275% | -5.637% |
Premier Inc. | 1.130% | -1.105% | -1.105% | - | - | - | - |
Onxeo S.A. | 1.120% | 2.785% | -17.227% | -64.229% | -46.403% | -86.284% | -87.584% |
Kalbe Farma | 1.110% | 2.235% | 21.192% | 7.647% | 18.065% | 94.681% | 7.647% |
Corvus Pharmaceuticals Inc | 1.100% | 0.409% | 58.280% | 103.315% | 142.105% | 95.745% | 15.397% |
Faes Farma S.A. | 1.100% | 1.243% | 4.416% | 12.251% | 15.615% | 11.670% | - |
IQVIA Holdings Inc. | 1.080% | 0.997% | 1.642% | 8.467% | 6.396% | 1.318% | 59.785% |
American Renal Associates Holdings Inc | 1.080% | - | - | - | - | - | - |
Masimo Corp. | 1.050% | -4.383% | 6.012% | 4.752% | -0.611% | -56.045% | -23.166% |
Riot Blockchain Inc. | 1.050% | -4.427% | -29.473% | -38.651% | -57.074% | -78.807% | 308.608% |
Sartorius Stedim Biotech S.A. | 1.050% | 4.691% | 5.384% | -28.627% | -23.877% | -64.603% | 33.870% |
Spark Therapeutics | 1.030% | - | - | - | - | - | - |
Laboratory Corp. Of America (labcorp) | 1.020% | - | - | - | - | - | - |
Global Cord Blood Corp. | 1.020% | - | - | - | - | - | - |
Taro Pharmaceutical Industries Ltd | 1.010% | - | - | - | - | - | - |